Your browser doesn't support javascript.
loading
Extended family thalassemia screening as a feasible alternative method to be implemented in identifying carriers in West Java, Indonesia.
Susanah, Susi; Sari, Nur Melani; Prihatni, Delita; Sinaga, Puspasari; Trisaputra, Jessica Oktavianus; Rakhmilla, Lulu Eva; Sribudiani, Yunia.
Afiliação
  • Susanah S; Department of Child Health, Hematology-Oncology Division, Dr. Hasan Sadikin General Hospital/Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia. susi_rshs@yahoo.co.id.
  • Sari NM; Department of Child Health, Hematology-Oncology Division, Dr. Hasan Sadikin General Hospital/Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia.
  • Prihatni D; Departement of Clinical Pathology, Dr. Hasan Sadikin General Hospital/Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia.
  • Sinaga P; Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia.
  • Trisaputra JO; Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia.
  • Rakhmilla LE; Department of Public Health, Epidemiology and Biostatistic Division, Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia.
  • Sribudiani Y; Department of Biomedical Sciences, Biochemistry and Molecular Biology Divison, Faculty of Medicine, Universitas Padjadjaran, Bandung, 40161, Indonesia.
J Community Genet ; 13(1): 103-112, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34783993
ABSTRACT
The thalassemia screening program in Indonesia mostly conducted sporadically. Ideal prospective screening is still limited. This study aimed to compare thalassemia screening methods using the extended family approach with and without a history of severe thalassemia and the feasibility of implementing extended family screening method. A case control study was conducted in Dr. Hasan Sadikin General Hospital Bandung with 3 generations of extended families. Data were collected from 150 subjects of 8 extended families with severe thalassemia as an index case entry and 151 subjects of 12 families with no history of thalassemia. All subjects were examined for Hb, MCV, MCH, and peripheral blood smear (PBS) as initial laboratory examinations. Subjects with MCV < 80 fL, MCH < 27 pg, and suggestive findings on PBS continued hemoglobin analysis. Carrier status was determined by definition. All subjects consented to undergo screening and voluntarily participated. The proportion of thalassemia carriers and the participation rate between the 2 groups were compared. Sixty-four of 150 (42.7%) and 16 of 151 (10.6%) carriers were identified in both the case and control group (p < 0.001). The participation rate was 42-88 vs. 23-100% (p = 0.244). The mean age was 31.9 ± 21.2 vs. 31.1 ± 20.8 years (p = 0.782). The median family size was 28.5 vs. 20 subjects per family (p = 0.245). The types of identified thalassemia carrier in both groups consisted of ß-thalassemia, ß-thalassemia/HbE, suspected α-thalassemia, and ß-thalassemia Hb variant. All carriers continued the counseling process. The extended family method seems feasible to be implemented for thalassemia screening in West Java, Indonesia.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article